41 completed. 41 Phase 1, 15 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 41 | Completed 41 |
| Phase 2 | 15 | Completed 15 |
Follow Ascorbic Acid: new trials by email Literature Review of Ascorbic Acid trials Research Report on Ascorbic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets Omeprazole 20mg, Vitamin C - Hypochlorhydria | Phase 1 | Completed | Indiana University | 11 | 2021-10-01 | 2025-09-22 |
| Trial of Combination Therapy to Treat COVID-19 Infection Ivermectin, Doxycycline Hcl, Zinc - COVID, Covid-19 | Phase 1 | Completed | ProgenaBiome | 31 | 2020-12-09 | 2024-09-24 |
| Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation L-ascorbic acid - COVID-19, Hypoxia | Phase 1 / Phase 2 | Completed | Hunter Holmes Mcguire Veteran Affairs Medical Center | 20 | 2020-04-16 | 2022-02-25 |
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas Ascorbate - Soft Tissue Sarcoma | Phase 1 / Phase 2 | Completed | Mohammed Milhem | 25 | 2019-06-27 | 2026-06-18 |
| High Dose Ascorbic Acid for Plasma Cell Disorders Ascorbate, Melphalan - Multiple Myeloma | Phase 1 | Completed | Christopher Strouse | 6 | 2019-03-05 | 2025-10-21 |
| Local Antioxidant Therapy Vasoconstriction Effects in Different Races Control (Norepinephrine), Norepinephrine + Ascorbic Acid, Norepinephrine + L-NAME - Cardiovascular Diseases, Cardiovascular Risk Factor | Phase 1 | Completed | The University of Texas at Arlington | 22 | 2018-10-15 | 2024-06-11 |
| UVB-Induced MVP Release in Human Skin Vitamin C, Vitamin E - Ultraviolet B Radiation, Microvesicle Particles | Phase 1 | Completed | Wright State University | 8 | 2018-07-16 | 2023-02-24 |
| A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations Vitamin C - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Completed | NYU Langone Health | 4 | 2018-05-01 | 2024-03-27 |
| Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia Vitamin C, placebo - Preeclampsia Severe, Preeclampsia Postpartum | Phase 1 | Completed | University Medical Centre Ljubljana | 34 | 2018-04-07 | 2019-06-28 |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) High Dose Ascorbic Acid 25 g/m^2, Nanoparticle Paclitaxel protein bound 125mg/m^2, Cisplatin 25mg/m^2 - Pancreatic Cancer, Pancreas Cancer | Phase 1 / Phase 2 | Completed | HonorHealth Research Institute | 17 | 2017-12-15 | 2026-07-23 |
| Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0 Ascorbic Acid - Lung Transplant | Phase 1 | Completed | Duke University | 6 | 2017-12-11 | 2019-07-05 |
| Vitamin C in Cardiac Surgery Patients Ascorbic Acid - Coronary Artery Bypass Graft Surgery | Phase 1 | Completed | Geisinger Clinic | 6 | 2017-07-06 | 2021-06-16 |
| The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists Mirabegron, B Complex Plus Vitamin C Tablets - Polycystic Ovary Syndrome | Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 55 | 2017-03-13 | 2026-09-09 |
| Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring Dermaroller, Topical Vitamin C - Acne Vulgaris, Acne Scars | Phase 1 / Phase 2 | Completed | Sohag University | 30 | 2016-06-01 | 2018-05-14 |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer vitamin C, Modulated Electro-Hyperthermia (mEHT), Supportive care - Carcinoma, Non-Small-Cell Lung, Stage IIIA Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Clifford Hospital, Guangzhou, China | 97 | 2015-12-01 | 2018-11-30 |
| Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD). Ibuprofen, Magnesium, Ascorbic Acid - Temporomandibular Joint Disorders | Phase 1 / Phase 2 | Completed | Spherium Biomed | 96 | 2015-12-01 | 2017-01-19 |
| A Pharmacokinetics Study of Intravenous Ascorbic Acid Ascor L 500® (Ascorbic Acid Injection, USP) - Pharmacokinetics | Phase 1 | Completed | McGuff Pharmaceuticals, Inc. | 8 | 2015-09-01 | 2016-03-23 |
| "Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects Ascorbic Acid - Vitamin C Deficiency | Phase 1 | Completed | Semmelweis University | 32 | 2015-06-01 | 2015-11-17 |
| Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women Alpha tocopherol, Vitamin E, Vitamin C - Diabetes, Fatty Liver | Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 50 | 2014-10-10 | 2026-10-30 |
| Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients Melphalan, Prednisone, Cyclophosphamide - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Oncotherapeutics | 45 | 2014-09-01 | 2023-10-31 |
Showing 20 of 41. Sign in to see all of them.
Multiple Myeloma (6) · Neoplasms (4) · Neoplasms, Plasma Cell (3) · Obesity (3) · Pancreatic Neoplasms (3) · Acute Lung Injury (2) · Asthma (2) · COVID-19 (2) · Diabetes Mellitus, Type 2 (2) · Myelodysplastic Syndromes (2) · Sepsis (2) · Severe Acute Respiratory Syndrome (2) · Achlorhydria (1) · Acne Vulgaris (1) · Alzheimer Disease (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Indiana University (2) · Jeanne Drisko, MD, CNS, FACN (2) · M.D. Anderson Cancer Center (2) · Barbara Ann Karmanos Cancer Institute (1) · Christopher Strouse (1) · Clifford Hospital, Guangzhou, China (1) · Duke University (1) · Geisinger Clinic (1) · HonorHealth Research Institute (1) · Hunter Holmes Mcguire Veteran Affairs Medical Center (1) · Jewish General Hospital (1) · Joseph J. Cullen (1) · Joseph J. Cullen, MD, FACS (1) · McGuff Pharmaceuticals, Inc. (1)
United States (34) · Canada (1) · China (1) · Egypt (1) · Germany (1) · Hungary (1) · Slovenia (1) · Spain (1)
Jeanne Drisko, MD (2) · Mark A Levine, M.D. (2) · Muzaffar H. Qazilbash, MD (2) · Aaron M Cypess, M.D. (1) · Alpha Fowler, MD (1) · Brian C Davis, MD (1) · Christopher Lis (1) · Christopher Strouse, MD (1) · Damon P Jones, BS/MBA (1) · Daniel A Monti, MD, MBA (1) · David B. Peden, MD, MS (1) · Deepak Singh, MD (1) · Douglas Galasko, MD (1) · Gayle S Jameson, RN, MSN, ACNP-BC, AOCN (1) · Giner Lluis, MD (1)
PMID 12473574, PMID 19433800, PMID 21815182, PMID 22431837, PMID 24484547, PMID 24500406, PMID 25848948, PMID 28366679, PMID 29215048, PMID 30254147, PMID 31495886, PMID 31821172, PMID 33184629, PMID 33453456, PMID 35135310, PMID 35750958, PMID 39702045, PMID 41197185
P01AT002620 (1), P30CA022453 (1), P30CA086862 (1), U01CA140206 (1)